• Automating Authorizations for Molecular Diagnostics Criteria


Authorization processes often are tedious, lengthy and expensive for both payors and providers. These issues are compounded in the fast-growing area of molecular diagnostics where new tests are coming to market nearly every week—payors and providers need real-time access to the latest information on test efficacy and coverage guidelines.

This is why InterQual® Molecular Diagnostics Criteria are being introduced with McKesson’s new Clear Coverage™, an interactive web-based service that gives payors and providers unprecedented efficiency in the authorization process.

Clear Coverage automates the entire authorization process, from the initial request all the way through final authorization. This auto authorization capability currently incorporates InterQual Molecular Diagnostics Criteria and a list of the highest volume or cost Imaging and Procedures Criteria. With Clear Coverage, medical appropriateness for these advanced diagnostics is determined automatically at the point of care.

Clear Coverage plus InterQual content offers critical advantages for payors and providers:

  • streamlines processes with real-time auto authorizations—plus automated eligibility checking, automatic notifications and payment estimations
  • reduces administrative costs by completely eliminating many manual processes
  • improves speed-of-care with instant medical necessity determinations and faster authorizations
  • enables more effective payor-provider collaboration by making the authorization process faster and more transparent.

Clear Coverage solutions are powered by McKesson’s Advanced Diagnostics Management platform.



Print page        
share Share this page

© 2009 McKesson Corp.